EyePoint Pharmaceuticals (EYPT) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Join SI Premium – FREE
EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q1 EPS of ($0.99), $0.17 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $696 thousand versus the consensus estimate of $1.01 million.
For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- DeFi Development closes $11M preferred stock offering backed by Solana
- GE Aerospace to acquire Consolidated Precision in $11.75b deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
